GENETIC ANALYSIS OF RAS TRANSFORMATION AND JUN FUNCTION

RAS 转化和 Jun 功能的遗传分析

基本信息

项目摘要

DESCRIPTION: (adapted from applicant's abstract): A critical link between the activation of the ras proto-oncogene and transcriptional activation is the transactivation of c-Jun and AP-1 transcription factors. The applicant has created a null mutation of c-jun in the mouse. Primary cells derived from such embryos growth arrest immediately in culture. Growth arrest can be overcome by co-transformation with large T antigen and activated Ras; however, these cells, unlike wild type cells transformed by the same agents, remain non-tumorigenic. These data indicate a critical role of c-jun in Ras induced tumor formation. The applicant proposes to further elucidate this role using a combined biochemical and genetic approach. First, he will perform targeted replacement of c-jun with a S63/S73 mutant, to assess role of JNK-mediated phosphorylation on c-jun function in vivo. Similar approaches will be used to determine the role of and the requirement for the delta region, which is thought to play a role both in JNK recruitment and in ubiquitination/destabilization of c-jun. The possible redundancy of different c-jun genes will be assessed by studies in which c-jun is replaced by jun B or jun D. In addition, the applicant will assess the role of junD directly by performing a junD knockout. Finally, the applicant will use a novel in vivo assay of tumorigenic establishment and screen for candidate target genes involved in ras/AP-1 mediate tumorigenesis.
描述:(改编自申请人的摘要):一个关键的环节之间

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RANDALL Scott JOHNSON其他文献

RANDALL Scott JOHNSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RANDALL Scott JOHNSON', 18)}}的其他基金

Myeloid Vascular Endothelial Growth Factor Expression & its Role in Tumorigenesis
骨髓血管内皮生长因子表达
  • 批准号:
    8065271
  • 财政年份:
    2011
  • 资助金额:
    $ 32.25万
  • 项目类别:
Myeloid Vascular Endothelial Growth Factor Expression & its Role in Tumorigenesis
骨髓血管内皮生长因子表达
  • 批准号:
    8449485
  • 财政年份:
    2011
  • 资助金额:
    $ 32.25万
  • 项目类别:
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant Infections
通过 HIF 增强先天免疫力来治疗抗生素耐药性感染
  • 批准号:
    8638886
  • 财政年份:
    2011
  • 资助金额:
    $ 32.25万
  • 项目类别:
Myeloid Vascular Endothelial Growth Factor Expression & its Role in Tumorigenesis
骨髓血管内皮生长因子表达
  • 批准号:
    8210931
  • 财政年份:
    2011
  • 资助金额:
    $ 32.25万
  • 项目类别:
Myeloid Vascular Endothelial Growth Factor Expression & its Role in Tumorigenesis
骨髓血管内皮生长因子表达
  • 批准号:
    8597539
  • 财政年份:
    2011
  • 资助金额:
    $ 32.25万
  • 项目类别:
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant Infections
通过 HIF 增强先天免疫力来治疗抗生素耐药性感染
  • 批准号:
    8076598
  • 财政年份:
    2011
  • 资助金额:
    $ 32.25万
  • 项目类别:
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant Infections
通过 HIF 增强先天免疫力来治疗抗生素耐药性感染
  • 批准号:
    8251149
  • 财政年份:
    2011
  • 资助金额:
    $ 32.25万
  • 项目类别:
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant Infections
通过 HIF 增强先天免疫力来治疗抗生素耐药性感染
  • 批准号:
    8448237
  • 财政年份:
    2011
  • 资助金额:
    $ 32.25万
  • 项目类别:
Boosting Innate Immunity Through HIF to Treat Drug-Resistant Bacterial Infections
通过 HIF 增强先天免疫来治疗耐药细菌感染
  • 批准号:
    8116223
  • 财政年份:
    2010
  • 资助金额:
    $ 32.25万
  • 项目类别:
Hypoxia-induced Responses and Innate Immunity
缺氧引起的反应和先天免疫
  • 批准号:
    6918864
  • 财政年份:
    2005
  • 资助金额:
    $ 32.25万
  • 项目类别:

相似海外基金

Albumin hitchhiking siRNAs for gene targeting in aged brain
白蛋白搭便车 siRNA 用于老年大脑基因靶向
  • 批准号:
    10611521
  • 财政年份:
    2022
  • 资助金额:
    $ 32.25万
  • 项目类别:
Albumin hitchhiking siRNAs for gene targeting in aged brain
白蛋白搭便车 siRNA 用于老年大脑基因靶向
  • 批准号:
    10467737
  • 财政年份:
    2022
  • 资助金额:
    $ 32.25万
  • 项目类别:
Basic research on nucleic acids therapeutics for IL-12p40 gene targeting
IL-12p40基因靶向核酸治疗的基础研究
  • 批准号:
    20K16082
  • 财政年份:
    2020
  • 资助金额:
    $ 32.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A new bladder cancer model based on tissue reprogramming and gene targeting
基于组织重编程和基因靶向的新膀胱癌模型
  • 批准号:
    10084281
  • 财政年份:
    2020
  • 资助金额:
    $ 32.25万
  • 项目类别:
A new bladder cancer model based on tissue reprogramming and gene targeting
基于组织重编程和基因靶向的新膀胱癌模型
  • 批准号:
    9896122
  • 财政年份:
    2020
  • 资助金额:
    $ 32.25万
  • 项目类别:
Multiplex gene targeting with CRISPR/Cas9 using single guide RNAs
使用单引导 RNA 通过 CRISPR/Cas9 进行多重基因打靶
  • 批准号:
    540963-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 32.25万
  • 项目类别:
    University Undergraduate Student Research Awards
Development of conditional and inducible gene targeting tools in rabbits
兔子条件性和诱导性基因打靶工具的开发
  • 批准号:
    9317588
  • 财政年份:
    2017
  • 资助金额:
    $ 32.25万
  • 项目类别:
Core B: Transgenic and Gene-Targeting Institutional Facility
核心 B:转基因和基因靶向机构设施
  • 批准号:
    10215556
  • 财政年份:
    2017
  • 资助金额:
    $ 32.25万
  • 项目类别:
Exploring function of mu opioid receptor splice variants in rat by gene targeting
通过基因打靶探索大鼠μ阿片受体剪接变体的功能
  • 批准号:
    9312277
  • 财政年份:
    2016
  • 资助金额:
    $ 32.25万
  • 项目类别:
Mechanistic Study and Gene Targeting to Block HIV Assembly by IN-Binding Protein
通过 IN 结合蛋白阻断 HIV 组装的机制研究和基因靶向
  • 批准号:
    9377499
  • 财政年份:
    2016
  • 资助金额:
    $ 32.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了